Psychosocial Support Improves Treatment Adherence Among MDR-TBPatients: Experience from East Kazakhstan

G. Kaliakbarova, S. Pak, N. Zhaksylykova, G. Raimova, B. Temerbekova, S. Hof
{"title":"Psychosocial Support Improves Treatment Adherence Among MDR-TBPatients: Experience from East Kazakhstan","authors":"G. Kaliakbarova, S. Pak, N. Zhaksylykova, G. Raimova, B. Temerbekova, S. Hof","doi":"10.2174/1874279301307010060","DOIUrl":null,"url":null,"abstract":"A novel patient-oriented treatment delivery program was introduced for multi-drug resistant tuberculosis (MDR-TB) patients at high risk of treatment default in East Kazakhstan region, The Republic of Kazakhstan. In parallel interventions were introduced to improve programmatic and clinical management for all MDR-TB patients. To assess the effects of the patient support program on patient default rates, we analyzed the characteristics of MDR-TB patients referred to the psychosocial support (PSS) program, treatment adherence before and during the intervention for patients referred to the patient support program. In 2010, the total numberf MDR-patients starting second-line drug MDR-TB treatment was 426. The PSS program supported 228 (53%) patients considered to be at high risk of treatment default. The program contributed to strengthening of management of all MDR-TB patients during the ambulatory, continuation phase of treatment. The proportion of drug doses taken under direct observation improved from 48% to 97%, while division of intake of second-line anti-TB drugs in 2-3 portions per day decreased from 20% in 2009 to 0%. Interruptions of anti-TB drugs for at least one day decreased from 18% to 4% among all MDR-TB patients. Among patients included in the PSS program, no treatment default was observed and only one patient missed doses of treatment.","PeriodicalId":88330,"journal":{"name":"The open infectious diseases journal","volume":"7 1","pages":"60-64"},"PeriodicalIF":0.0000,"publicationDate":"2013-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"27","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The open infectious diseases journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874279301307010060","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 27

Abstract

A novel patient-oriented treatment delivery program was introduced for multi-drug resistant tuberculosis (MDR-TB) patients at high risk of treatment default in East Kazakhstan region, The Republic of Kazakhstan. In parallel interventions were introduced to improve programmatic and clinical management for all MDR-TB patients. To assess the effects of the patient support program on patient default rates, we analyzed the characteristics of MDR-TB patients referred to the psychosocial support (PSS) program, treatment adherence before and during the intervention for patients referred to the patient support program. In 2010, the total numberf MDR-patients starting second-line drug MDR-TB treatment was 426. The PSS program supported 228 (53%) patients considered to be at high risk of treatment default. The program contributed to strengthening of management of all MDR-TB patients during the ambulatory, continuation phase of treatment. The proportion of drug doses taken under direct observation improved from 48% to 97%, while division of intake of second-line anti-TB drugs in 2-3 portions per day decreased from 20% in 2009 to 0%. Interruptions of anti-TB drugs for at least one day decreased from 18% to 4% among all MDR-TB patients. Among patients included in the PSS program, no treatment default was observed and only one patient missed doses of treatment.
心理社会支持提高耐多药结核患者的治疗依从性:来自东哈萨克斯坦的经验
在哈萨克斯坦共和国东哈萨克斯坦地区,针对存在治疗违约高风险的耐多药结核病(MDR-TB)患者推出了一项以患者为导向的新型治疗方案。同时,还引入了干预措施,以改善对所有耐多药结核病患者的规划和临床管理。为了评估患者支持计划对患者违约率的影响,我们分析了参与心理社会支持(PSS)计划的耐多药结核病患者的特征,以及参与患者支持计划的患者在干预前和干预期间的治疗依从性。2010年,开始二线耐多药结核病治疗的耐多药患者总数为426人。PSS项目支持了228例(53%)被认为存在治疗违约高风险的患者。该规划有助于加强在门诊、继续治疗阶段对所有耐多药结核病患者的管理。直接观察下服用药物的比例从48%提高到97%,每天2-3份的二线抗结核药物的摄入比例从2009年的20%下降到0%。在所有耐多药结核病患者中,中断使用抗结核药物至少一天的比例从18%降至4%。在纳入PSS计划的患者中,没有观察到治疗违约,只有一名患者错过了治疗剂量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信